Client
- Name
- BRAINFUTURES
- Description
- Nonprofit advocate for therapeutic treatments for mental health and substance use disorder
- Location
- Maryland · United States of America
Registrant
- Firm
- HOOPER, LUNDY & BOOKMAN, P.C.
- Description
- law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies, including reimbursement and workforce; S. 331 - HALT Fentanyl Act, provisions related to research.; H.R. 3944 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, funding and report language related to psychedelic research.
LobbyistsLISA LAYMAN
Covered position (LISA LAYMAN): SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Issues related to a pathway for FDA approval of psychedelic drugs and therapies; Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, including reimbursement and workforce; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.
LobbyistsLISA LAYMAN
Covered position (LISA LAYMAN): SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
SENATE · HOUSE OF REPRESENTATIVES